Neuropharmagen® is a breakthrough in pharmacogenetics that helps to identify the safest and most appropriate psychotropic medication for each patient, by analyzing their DNA. It provides the most extensive genetic-based information on drug efficacy, metabolism and adverse effects.
Neuropharmagen® helps reduce the time spent searching for the most effective treatment choices unique to each patient. This allows for a faster stabilization of patients and better quality of life..
Neuropharmagen® testing is carried out on a saliva sample:
- DNA markers of efficacy, optimal dosage and adverse effects are analyzed.
- A series of specific recommendations are provided based on the test results, to help the physician choose the most appropriate choices for each patient.
Identifying these parameters and knowing that there may be a better alternative at the beginning of a long treatment of a psychiatric patient makes this genetic marker test a therapeutic tool too good to ignore it.
Vega M. Psiquiatria.com. 2012; 16:5.
LGF is a 40 year-old woman with a schizoid-affective disorder. She had a poor response to treatment with poor metabolism. After being analyzed at her psychiatrist’s suggestion with Neuropharmagen, the results allowed her doctor to improve her treatment in accordance with her genetic profile: in this case, the prescribed dosage of Seroquel and Citalopram were increased.